TTD | Drug: D05XLD

Drug General Information
Drug ID	D05XLD
Former ID	DNC008431
Drug Name	Piridronic acid
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[540162]
Structure		Download 2D MOL 3D MOL
Formula	C7H11NO6P2
InChI	InChI=1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)5-6-3-1-2-4-8-6/h1-4,7H,5H2,(H2,9,10,11)(H2,12,13,14)
InChIKey	NGMZSXZBZNXBGX-UHFFFAOYSA-N
PubChem Compound ID	57637
PubChem Substance ID	8185350, 15197241, 43115307, 76483666, 103313949, 104313190, 117401064, 126421310, 128699093, 134345636, 135026996, 135650705, 142216117, 160852197, 179323430, 198949788, 226576473
Target and Pathway
Target(s)	Farnesyl pyrophosphatesynthetase	Target Info	Inhibitor	[529362]
KEGG Pathway	Terpenoid backbone biosynthesis
	Metabolic pathways
	Biosynthesis of antibiotics
	Influenza A
	HTLV-I infection
PathWhiz Pathway	Steroid Biosynthesis
Reactome	Cholesterol biosynthesis
Reactome	Activation of gene expression by SREBF (SREBP)
WikiPathways	Activation of Gene Expression by SREBP (SREBF)
	SREBP signalling
	Cholesterol Biosynthesis
References
Ref 540162	(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3183).
Ref 529362	J Med Chem. 2008 Apr 10;51(7):2187-95. Epub 2008 Mar 8.Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information